. . . . . . . "[In responders, octreotide (n = 2 out of 4; -30.5% � 10.4%) was less potent than pasireotide (n = 5 out of 6; -47.0% � 4.2%) and cabergoline (n = 3 out of 4; -41.9% � 3.1%) with respect to inhibition of ACTH secretion by adenomas from group 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:15:32+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .